{
  "nctId": "NCT01822353",
  "briefTitle": "The Effect of Per Oral Immunotherapy in Severe IgE Mediated Egg, Milk, and Nut Allergy in Adults",
  "officialTitle": "The Effect of Per Oral Immunotherapy in Severe IgE Mediated Egg, Milk and Nut Allergy in Adults",
  "protocolDocument": {
    "nctId": "NCT01822353",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2012-10-19",
    "uploadDate": "2019-06-27T11:04",
    "size": 190200,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT01822353/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NON_RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 23,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2013-01",
    "completionDate": "2017-11",
    "primaryCompletionDate": "2017-11",
    "firstSubmitDate": "2013-03-07",
    "firstPostDate": "2013-04-02"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* severe IgE-mediated milk allergy or\n* severe IgE-mediated egg allergy or\n* severe IgE-mediated nut allergy or\n* 18-50 years\n\nExclusion Criteria:\n\n* instable cerebrovascular or heart disease\n* active autoimmune disease or cancer\n* use of betablocker agents\n* poorly controlled asthma\n* FEV1 \\< 70% of the predicted",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "50 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of the Patients That Achieve Higher Tolerance of Allergen With Immunotherapy",
        "description": "Number of the patients that achieve higher tolerance of allergen with immunotherapy in one year than the measured baseline allergen challenge shows.",
        "timeFrame": "One year"
      }
    ],
    "secondary": [
      {
        "measure": "Effect of Therapy on Lung Function.",
        "description": "Does hyposensitisation change lung function (do spirometry tests show difference from the baseline values (= before immunotherapy) after the immunotherapy) ?",
        "timeFrame": "One year"
      },
      {
        "measure": "Does Oral Immunotherapy Change Bronchial Hyperreactivity?",
        "description": "Does bronchial hyperreactivity (measured with methacholine bronchial challenge test) show change from the baseline level after the immunotherapy?",
        "timeFrame": "One year"
      },
      {
        "measure": "Does the Oral Immunotherapy Have en Effect on Airway Inflammation?",
        "description": "Does the oral immunotherapy change exhaled nitric oxide levels (measured before and after immunotherapy)",
        "timeFrame": "One year"
      }
    ],
    "other": [
      {
        "measure": "Safety of Oral Immunotherapy in Severe IgE Mediated Food Allergy in Adults.",
        "description": "How many of the patients have side effects (categorized as mild, moderate or severe)of the hyposensitisation and how many of the patients discontinue the therapy because of side effects?",
        "timeFrame": "One year"
      },
      {
        "measure": "Effect of Treatment on Quality of Life",
        "description": "Quality of life is assessed by a questionnaire before and after immunotherapy (VAS scale on worries on allergy 0-100, 0 no worries, 100 maximal worries).",
        "timeFrame": "one year"
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 3,
      "otherCount": 2,
      "totalCount": 6
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 33,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:47.698Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}